National Institute for Occupational Safety and Health Personal Protective Technology Program and National Personal Protective Technology Laboratory Conformity Assessment; Extension of Comment Period, 60874-60875 [2013-23982]
Download as PDF
tkelley on DSK3SPTVN1PROD with NOTICES
60874
Federal Register / Vol. 78, No. 191 / Wednesday, October 2, 2013 / Notices
in grant application HL113518–01 to
support the hypothesis of the research.
The falsified and/or fabricated data are:
• False +-actin data and statistics in
Figures 1A and 1B in the AJP paper and
Figures 41A and 41B in the thesis (p.
131) that purport to represent a timecourse of 15–LO–1 protein expression in
rabbit aortic endothelial cells (RAECs)
following hypoxia.
• false +-actin and 15–LO–1 data and
statistics in Figures 2A and 2B in the
AJP paper and Figures 45A and 45B in
the thesis (p. 135) that purport to
represent 15–LO–1 expression in aortic
rings of normoxic and hypoxic rabbits.
• false +-actin data and statistics in
Figures 3A and 3B in the AJP paper and
Figures 46A and 46B in the
Respondent’s Ph.D. thesis (p. 137) that
purport to represent 15–LO–1
expression in different arteries after
hypoxia.
• false +-actin data and statistics in
Figures 1A and 1B in the ATVB paper
and Figures 26A and 26B in the thesis
(p. 105) that purport to demonstrate
changes in 15–LO–1 expression in
different arteries of cholesterol-animals;
the false +-actin data in Figure 1A,
ATVB was the same image as that used
for Figure 1A, AJP but flipped vertically.
• false GAPDH data and statistics in
Figure 7 in the AHA grant application
that purport to represent SUR2A–55
expression in murine heart following
left ventricular hypertrophy (LVH).
• false reporting in Figure 4A of grant
application HL113518–01 for the
number of mice used for the
physiological data for ATP-induced
potassium influx in murine
mitochondria as three to four, when
only a single mouse was studied.
Dr. Aggarwal has entered into a
Voluntary Settlement Agreement and
has voluntarily agreed for a period of
three (3) years, beginning on September
17, 2013:
(1) To have his research supervised;
Respondent agreed that prior to the
submission of an application for U.S.
Public Health Service (PHS) support for
a research project on which his
participation is proposed and prior to
his participation in any capacity on
PHS-supported research, Respondent
shall ensure that a plan for supervision
of his duties is submitted to ORI for
approval; the supervision plan must be
designed to ensure the scientific
integrity of his research contribution; he
agreed that he shall not participate in
any PHS-supported research until such
a supervision plan is submitted to and
approved by ORI; Respondent agreed to
maintain responsibility for compliance
with the agreed upon supervision plan;
VerDate Mar<15>2010
17:48 Oct 01, 2013
Jkt 232001
(2) that any institution employing him
shall submit in conjunction with each
application for PHS funds, or report,
manuscript, or abstract involving PHSsupported research in which
Respondent is involved, a certification
to ORI that the data provided by
Respondent are based on actual
experiments or are otherwise
legitimately derived, and that the data,
procedures, and methodology are
accurately reported in the application,
report, manuscript, or abstract; and
(3) to exclude himself voluntarily
from serving in any advisory capacity to
PHS including, but not limited to,
service on any PHS advisory committee,
board, and/or peer review committee, or
as a consultant.
FOR FURTHER INFORMATION CONTACT:
Director, Office of Research Integrity,
1101 Wootton Parkway, Suite 750,
Rockville, MD 20852, (240) 453–8200.
David E. Wright,
Director, Office of Research Integrity.
[FR Doc. 2013–23971 Filed 10–1–13; 8:45 am]
BILLING CODE 4150–31–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[CDC–2013–0015; NIOSH–237–A]
National Institute for Occupational
Safety and Health Personal Protective
Technology Program and National
Personal Protective Technology
Laboratory Conformity Assessment;
Extension of Comment Period
The National Institute for
Occupational Safety and Health
(NIOSH) of the Centers for Disease
Control and Prevention (CDC),
Department of Health and Human
Services (HHS).
ACTION: Notice and extension of
comment period.
AGENCY:
On August 14, 2013, the
Director of the National Institute for
Occupational Safety and Health
(NIOSH) of the Centers for Disease
Control and Prevention (CDC) published
a notice in the Federal Register [78 FR
49524] announcing a public meeting.
This meeting was held on September 17,
2013 to provide (1) a summary of the
work conducted by the NIOSH Personal
Protective Technology (PPT) Conformity
Assessment Working Group (PCAWG),
(2) provide an overview of model
Conformity Assessment programs, and
(3) solicit input to define a national
SUMMARY:
PO 00000
Frm 00059
Fmt 4703
Sfmt 4703
framework for PPE conformity
assessment.
NIOSH’s National Personal Protective
Technology Laboratory (NPPTL) is
addressing recommendations of the
Institute of Medicine (IOM) and the
National Research Council based on a
review of NPPTL’s program activities.
The IOM report identified gaps and
inconsistencies in the certification and
other conformity assessment processes
for non-respiratory PPT. Conformity
assessment is defined as the
‘‘demonstration that specified
requirements relating to a product,
process, system, person or body are
fulfilled.’’ Conformity assessment
processes for PPT products are focused
on product effectiveness and include
the following primary components:
Certification (ISO/IEC 17065),
Inspection (ISO/IEC 17020), Testing
(ISO/IEC 17025), Accreditation (ISO/IEC
17011), Surveillance (ISO/IEC 17011,
ISO/IEC 17065), Supplier’s Declaration
of Conformity (ISO/IEC 17050),
Registration (ISO/IEC 17021) and
Quality management systems (ISO/
9001).
Written comments were to be received
by September 30, 2013. NIOSH is
extending the public comment period to
December 2, 2013.
You may submit comments by either
of the following methods:
• Federal eRulemaking Portal: https://
www.regulations.gov. Follow the
instructions for submitting comments.
• Mail: NIOSH Docket Office, Robert
A. Taft Laboratories, MS–C34, 4676
Columbia Parkway, Cincinnati, OH
45226.
All information received in response
to this notice and meeting must include
the agency name and docket number
(CDC–2013–0015; NIOSH–237–A). All
relevant comments received will be
posted without change to https://
www.regulations.gov, including any
personal information provided. All
information will be available for public
examination and copying at the NIOSH
Docket Office, 4676 Columbia Parkway,
Room 109, Cincinnati, OH 45226. All
electronic comments should be
formatted in Microsoft Word.
To view the notice and related
materials, visit https://
www.regulations.gov and enter CDC–
2013–0015 in the search field and click
‘‘Search.’’
FOR FURTHER INFORMATION CONTACT:
Richard Metzler, General Engineer,
NIOSH at NPPTLEvents@cdc.gov,
telephone (412) 386–6686, fax (412)
386–6617.
E:\FR\FM\02OCN1.SGM
02OCN1
Federal Register / Vol. 78, No. 191 / Wednesday, October 2, 2013 / Notices
Dated: September 25, 2013.
John Howard,
Director, National Institute for Occupational
Safety and Health, Centers for Disease Control
and Prevention.
[FR Doc. 2013–23982 Filed 10–1–13; 8:45 am]
BILLING CODE 4163–19–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Assistant Secretary for Preparedness
and Response; Notification of a Sole
Source Cooperative Agreement Award
Department of Health and
Human Services (HHS), Assistant
Secretary for Preparedness and
Response (ASPR), Office of Emergency
Management (OEM).
ACTION: Notification of a sole source
Cooperative Agreement Award.
AGENCY:
Statutory Authority: Public Health Service
Act, Section 301.
tkelley on DSK3SPTVN1PROD with NOTICES
Estimated Amount of Award:
$200,000 to $ 750,000 (contingent on
the availability of funding).
Project Period: September 30, 2013 to
March 31, 2015.
Summary and Project Overview
The Office of Emergency Management
(OEM) within the Office of the Assistant
Secretary for Preparedness and
Response (ASPR) is responsible for
developing operational plans to ensure
the preparedness of the Office, the
Department, the Federal Government
and the public to respond to and recover
from domestic and international public
health and medical threats and
emergencies. OEM is also responsible
for ensuring that ASPR has the systems,
logistical support, and procedures
necessary to coordinate the
Department’s operational response to
acts of terrorism and other public health
and medical threats and emergencies.
OEM is responsible for leading
Emergency Support Function #8 (ESF
#8), Public Health and Medical Services,
under the National Response
Framework and the Health and Social
Services (H&SS) Recovery Support
Function (RSF) under the National
Disaster Recovery Framework (NDRF),
released in September 2011.
In the field of disaster and emergency
management, post-disaster recovery has
played an important, although often
lower profile role. When it is addressed,
it frequently references the restoration
of previously extant physical or
economic systems within a community,
with a focus on ‘‘bricks and mortar’’
infrastructure reconstitution (e.g. roads,
bridges, housing stock, commercial
VerDate Mar<15>2010
17:48 Oct 01, 2013
Jkt 232001
structures, etc) and/or business and
commercial recovery.i Oftentimes
absent from consideration is the critical
importance of health, and the public
health, medical and social services and
underlying determinants of health that
are key to supporting overall recovery.ii
Anecdotal evidence from recent
disasters and other scientific
evidence iii iv v suggest that there is not a
broad understanding of the recovery
activities that most significantly impact
the health of individuals of populations.
This grant will support the development
and distribution of a set of evidencebased recommendations that inform
recovery efforts in affected communities
and the work of both emergency
managers and health professionals. The
recommendations will be informed by
input from stakeholders and subject
matters experts.
Pursuant to the National Health
Security Strategy (NHSS) objective 8.3
and, specifically, sub-objective 8.3.1,
this grant will generally seek ‘‘to
continuously improve recovery efforts,
[through] data elements assess[ing]
recovery progress, quality, and
outcomes.’’ vi This grant also supports
HHS Strategic Plan Objective 3F: Protect
Americans’ health and safety during
emergencies, and foster resilience in
response to emergencies.
Justification
The Institute of Medicine (IOM) is a
nonprofit organization and is part of the
National Academy of Sciences. IOM
undertakes studies that may be specific
mandates from Congress or requested by
federal agencies and independent
organizations.
The IOM has an established Forum on
Medical and Public Health Preparedness
for Catastrophic Events. The Forum held
a panel on Long-term Recovery of the
Healthcare Service Delivery
Infrastructure in February 2012 during
the 2012 Public Health Preparedness
Summit in Anaheim, CA. The Forum’s
purpose is to foster dialogue among
stakeholders, identify opportunities for
public/private collaboration, and
identify and address issues relevant to
public health and medical
preparedness.
The IOM is part of the National
Academies, which also has an
established Disasters Roundtable. The
Disasters Roundtable holds workshops
three times per year on topics often
relevant to recovery partners. The IOM
is uniquely positioned to be able to not
only identify relevant partners and
stakeholders but also garner their
participation in the proposed activities
because of their existing structures and
established reputation.
PO 00000
Frm 00060
Fmt 4703
Sfmt 4703
60875
Additional Information: The agency
program contact is Esmeralda Pereira,
esmeralda.pereira@hhs.gov, 202–205–
0065.
Dated: September 27, 2013.
Nicole Lurie,
Assistant Secretary for Preparedness and
Response.
lllllllllllllllllllll
i Abramson, D., Stehling-Ariza, T., Soo
Park, Y., Walsh, L., Culp, D. 2010. Measuring
Individual Disaster Recovery: A
Socioecological Framework. Disaster
Medicine and Public Health Preparedness
4(S1): S46–S54.
ii Burkle, F. M. 2011. The Limits to Our
Capacity: Reflections on Resiliency,
Community Engagement, and Recovery in
21st Century Crises. Disaster Medicine and
Public Health Preparedness 5(S2): S176–
S181.
iii Masten, A.S., and Obradovic, J. 2007.
Disaster preparation and recovery: lessons
from research on resilience in human
development. Ecology and Society 13(1): 9.
[online] URL: https://
www.ecologyandsociety.org/vol13/iss1/art9/.
iv Wallace, D., and R. Wallace. 2007. Urban
Systems during Disasters: Factors in
Resilience. Ecology and Society 13(1): 18.
[online] URL: https://
www.ecologyandsociety.org/vol13/iss1/art18/
.
v Abramson, D., Soo Park, Y., StehlingAriza, T., Redlener, I. 2010. Children as
Bellwethers of Recovery: Dysfunctional
Systems and the Effects of Parents,
Households, and Neighborhoods on Serious
Emotional Disturbance in Children After
Hurricane Katrina. Disaster Medicine and
Public Health Preparedness 4(S1): S17–27.
vi NHSS.
[FR Doc. 2013–24096 Filed 9–30–13; 8:45 am]
BILLING CODE 4150–37–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel (SEP): Initial Review
The meeting announced below
concerns Occupational Safety and
Health Training Project Grants (T03),
PAR–10–288, initial review.
In accordance with Section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces the aforementioned meeting:
Time and Date: 8 a.m.—5 p.m.,
November 6, 2013 (Closed).
Place: Centers for Disease Control and
Prevention, Roybal Campus, Building
19–GCC, 1600 Clifton Road, Atlanta,
Georgia 30333, Telephone: (404) 639–
6000.
E:\FR\FM\02OCN1.SGM
02OCN1
Agencies
[Federal Register Volume 78, Number 191 (Wednesday, October 2, 2013)]
[Notices]
[Pages 60874-60875]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-23982]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[CDC-2013-0015; NIOSH-237-A]
National Institute for Occupational Safety and Health Personal
Protective Technology Program and National Personal Protective
Technology Laboratory Conformity Assessment; Extension of Comment
Period
AGENCY: The National Institute for Occupational Safety and Health
(NIOSH) of the Centers for Disease Control and Prevention (CDC),
Department of Health and Human Services (HHS).
ACTION: Notice and extension of comment period.
-----------------------------------------------------------------------
SUMMARY: On August 14, 2013, the Director of the National Institute for
Occupational Safety and Health (NIOSH) of the Centers for Disease
Control and Prevention (CDC) published a notice in the Federal Register
[78 FR 49524] announcing a public meeting. This meeting was held on
September 17, 2013 to provide (1) a summary of the work conducted by
the NIOSH Personal Protective Technology (PPT) Conformity Assessment
Working Group (PCAWG), (2) provide an overview of model Conformity
Assessment programs, and (3) solicit input to define a national
framework for PPE conformity assessment.
NIOSH's National Personal Protective Technology Laboratory (NPPTL)
is addressing recommendations of the Institute of Medicine (IOM) and
the National Research Council based on a review of NPPTL's program
activities. The IOM report identified gaps and inconsistencies in the
certification and other conformity assessment processes for non-
respiratory PPT. Conformity assessment is defined as the
``demonstration that specified requirements relating to a product,
process, system, person or body are fulfilled.'' Conformity assessment
processes for PPT products are focused on product effectiveness and
include the following primary components: Certification (ISO/IEC
17065), Inspection (ISO/IEC 17020), Testing (ISO/IEC 17025),
Accreditation (ISO/IEC 17011), Surveillance (ISO/IEC 17011, ISO/IEC
17065), Supplier's Declaration of Conformity (ISO/IEC 17050),
Registration (ISO/IEC 17021) and Quality management systems (ISO/9001).
Written comments were to be received by September 30, 2013. NIOSH
is extending the public comment period to December 2, 2013.
You may submit comments by either of the following methods:
Federal eRulemaking Portal: https://www.regulations.gov.
Follow the instructions for submitting comments.
Mail: NIOSH Docket Office, Robert A. Taft Laboratories,
MS-C34, 4676 Columbia Parkway, Cincinnati, OH 45226.
All information received in response to this notice and meeting
must include the agency name and docket number (CDC-2013-0015; NIOSH-
237-A). All relevant comments received will be posted without change to
https://www.regulations.gov, including any personal information
provided. All information will be available for public examination and
copying at the NIOSH Docket Office, 4676 Columbia Parkway, Room 109,
Cincinnati, OH 45226. All electronic comments should be formatted in
Microsoft Word.
To view the notice and related materials, visit https://www.regulations.gov and enter CDC-2013-0015 in the search field and
click ``Search.''
FOR FURTHER INFORMATION CONTACT: Richard Metzler, General Engineer,
NIOSH at NPPTLEvents@cdc.gov, telephone (412) 386-6686, fax (412) 386-
6617.
[[Page 60875]]
Dated: September 25, 2013.
John Howard,
Director, National Institute for Occupational Safety and Health,
Centers for Disease Control and Prevention.
[FR Doc. 2013-23982 Filed 10-1-13; 8:45 am]
BILLING CODE 4163-19-P